Fmr LLC Y M Abs Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 30,868 shares of YMAB stock, worth $265,773. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,868

Previous 29,261 5.49%

Holding current value

$265,773

Previous $129,000 7.75%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.64 - $5.35 $5,849 - $8,597	1,607 Added 5.49%	30,868 $139,000
Q1 2025 May 12, 2025	SELL	$4.43 - $8.17 $99,502 - $183,506	-22,461 Reduced 43.43%	29,261 $129,000
Q4 2024 Feb 13, 2025	BUY	$7.76 - $15.69 $118,774 - $240,151	15,306 Added 42.03%	51,722 $404,000
Q3 2024 Nov 13, 2024	BUY	$9.95 - $15.39 $67,878 - $104,990	6,822 Added 23.05%	36,416 $478,000
Q2 2024 Aug 13, 2024	BUY	$11.6 - $17.25 $18,884 - $28,083	1,628 Added 5.82%	29,594 $357,000
Q1 2024 May 13, 2024	SELL	$6.57 - $18.69 $58,315 - $165,892	-8,876 Reduced 24.09%	27,966 $454,000
Q4 2023 Feb 13, 2024	BUY	$4.88 - $7.42 $3,742 - $5,691	767 Added 2.13%	36,842 $251,000
Q3 2023 Nov 13, 2023	SELL	$4.86 - $7.23 $4,359 - $6,485	-897 Reduced 2.43%	36,075 $196,000
Q2 2023 Aug 11, 2023	BUY	$5.68 - $10.34 $202,560 - $368,745	35,662 Added 2722.29%	36,972 $251,000
Q1 2023 May 11, 2023	BUY	$2.83 - $5.11 $305 - $551	108 Added 8.99%	1,310 $6,000
Q4 2022 Feb 13, 2023	SELL	$3.0 - $15.17 $4.13 Million - $20.9 Million	-1,377,264 Reduced 99.91%	1,202 $5,000
Q3 2022 Nov 10, 2022	SELL	$13.96 - $19.67 $8.27 Million - $11.7 Million	-592,385 Reduced 30.06%	1,378,466 $19.9 Million
Q2 2022 Aug 12, 2022	BUY	$8.22 - $15.13 $4,792 - $8,820	583 Added 0.03%	1,970,851 $29.8 Million
Q1 2022 May 13, 2022	BUY	$6.55 - $17.42 $2.91 Million - $7.74 Million	444,481 Added 29.13%	1,970,268 $23.4 Million
Q3 2021 Nov 15, 2021	SELL	$27.47 - $37.31 $637,304 - $865,592	-23,200 Reduced 1.5%	1,525,787 $43.5 Million
Q2 2021 Aug 13, 2021	BUY	$25.45 - $37.64 $39.4 Million - $58.3 Million	1,548,987 New	1,548,987 $52.4 Million

Others Institutions Holding YMAB

# of Institutions

Shares Held

25.9M

Call Options Held

24K

Put Options Held

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $376M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account